ETFs holding Oruka Therapeutics, Inc. stocks
Below are funds with Oruka Therapeutics, Inc. stocks, sorted by market value. Equipped with price, change, and other helpful stats, they make investing in ORKA more accessible and offer more opportunities at a lower risk.
Symbol | Market value | Weight | Issuer | Management style | Focus | Expense ratio | AUM | Price | Change % | Rel Volume | NAV total return 3Y |
|---|---|---|---|---|---|---|---|---|---|---|---|
 IWNiShares Russell 2000 Value ETF | 4.91 M USD | 0.04% | BlackRock, Inc. | Passive | Small cap | 0.24% | 12.07 B USD | 177.77 USD | −1.13% | 1.07 | +44.87% |
| IBBiShares Biotechnology ETF | 3.68 M USD | 0.06% | BlackRock, Inc. | Passive | Health care | 0.44% | 6.21 B USD | 150.48 USD | −0.03% | 0.81 | +27.20% |
 XBISPDR S&P BIOTECH ETF | 3.57 M USD | 0.06% | State Street Corp. | Passive | Health care | 0.35% | 6.31 B USD | 103.68 USD | +0.04% | 0.68 | +31.25% |
| IWCiShares Micro-Cap ETF | 1.28 M USD | 0.13% | BlackRock, Inc. | Passive | Micro cap | 0.60% | 1.01 B USD | 152.90 USD | −1.05% | 3.39 | +52.49% |
 AVSCAvantis U.S Small Cap Equity ETF | 702.93 K USD | 0.04% | American Century Cos., Inc. | Active | Small cap | 0.25% | 1.96 B USD | 57.12 USD | −1.11% | 0.78 | +7.44% |
| BTEEiShares NASDAQ US Biotechnology UCITS ETF | 426.73 K USD | 0.07% | BlackRock, Inc. | Passive | Health care | 0.35% | 27.98 M USD | 7.331 USD | −0.45% | 0.07 | +34.53% |
| BTECiShares NASDAQ US Biotechnology UCITS ETF | 426.73 K USD | 0.07% | BlackRock, Inc. | Passive | Health care | 0.35% | 627.8 M USD | 7.3625 USD | −0.29% | 1.16 | +34.53% |
 SBIOInvesco NASDAQ Biotech UCITS ETF | 261.75 K USD | 0.07% | Invesco Ltd. | Passive | Health care | 0.40% | 385.39 M USD | 52.55 USD | −0.30% | 1.18 | +34.49% |
 VTWVVanguard Russell 2000 Value ETF | 258.87 K USD | 0.03% | The Vanguard Group, Inc. | Passive | Small cap | 0.10% | 853.58 M USD | 156.52 USD | −1.26% | 0.45 | +45.81% |
 LABUDirexion Daily S&P Biotech Bull 3X Shares | 234.45 K USD | 0.05% | Rafferty Asset Management LLC | Passive | Health care | 0.93% | 772.5 M USD | 103.53 USD | +0.08% | 0.84 | −23.57% |
 203780MIRAE ASSET TIGER NASDAQ BIO ETF | 31.26 K USD | 0.07% | Mirae Asset Global Investments Co., Ltd. | Passive | Health care | 0.30% | 46.63 M USD | 25,750 KRW | +2.77% | 1.53 | +26.43% |
| IBBQInvesco Nasdaq Biotechnology ETF | 28.79 K USD | 0.07% | Invesco Ltd. | Passive | Health care | 0.19% | 40.72 M USD | 25.31 USD | +0.34% | 0.51 | +35.24% |
 BIBProShares Ultra Nasdaq Biotechnology | 28.01 K USD | 0.05% | ProShare Advisors LLC | Passive | Health care | 0.95% | 62.42 M USD | 64.43 USD | +0.70% | 1.52 | +35.21% |
 CUREGlobal X S&P Biotech ETF | 13.37 K USD | 0.06% | Mirae Asset Global Investments Co., Ltd. | Passive | Health care | 0.45% | 23.42 M USD | 53.40 AUD | −0.19% | 0.54 | +25.96% |
 00678Capital Nasdaq Biotechnology Index ETF | 3.76 K USD | 0.04% | Qunyi Securities Investment Trust Co. Ltd. | Passive | Health care | 1.01% | 8.75 M USD | 29.85 TWD | +0.07% | 0.72 | +17.32% |
 PWSPacer WealthShield ETF | 3.62 K USD | 0.01% | Pacer Advisors, Inc. | Passive | Target outcome | 0.60% | 30.74 M USD | 32.36 USD | −0.65% | 1.66 | +18.41% |